2026 INDUSTRY GUIDE

How to Value an Urgent Care Clinic

EBITDA Multiples, Cap Rates, Deal Structures & What Buyers Pay in Today's Market

Written by The UCX Team — Published January 2026 | Updated Quarterly

Executive Summary

The urgent care industry has undergone a dramatic transformation over the past decade. With over 14,000 centers operating across the United States, the sector has attracted significant private equity investment, hospital system partnerships, and a wave of independent operator acquisitions. For buyers, sellers, and investors, accurately valuing an urgent care clinic has never been more important — or more complex.

This guide, produced by the UCX Team at UrgentCareExchange.com, consolidates the most current data on valuation methodologies, EBITDA multiples, deal structures, and market dynamics entering 2026. Whether you are preparing a clinic for sale, evaluating an acquisition target, or simply benchmarking your existing operations, this resource is designed to give you a clear, practical framework.

Key Findings at a Glance

• The urgent care market is projected to exceed $47 billion by 2030, growing at approximately 5.8% annually.
• EBITDA multiples for well-performing urgent care groups ranged from 6x to 12x in 2025 transactions.
• Private equity accounted for 17% of all urgent care centers by late 2024, a figure expected to rise through 2026.
• Multi-location groups (3+ sites) command a meaningful premium of 1.5x to 3x over single-site practices.
• Occupational health integration, strong payer mix, and proprietary EMR data are now top value drivers.
• Buyers in 2026 are placing increased weight on technology infrastructure, clinical staffing stability, and geographic market position.

Section 1: The State of the Urgent Care Market in 2026

1.1 Industry Scale & Growth

Urgent care has evolved from a convenience alternative to emergency rooms into a foundational pillar of the American healthcare system. As of late 2024, there were more than 14,245 urgent care centers in the United States, representing a sector that has grown by over 60% since 2014. The industry now sees an estimated 160 million patient visits annually.

The sector is projected to reach $47 billion in market size by 2030, driven by continued consumer preference for accessible, cost-effective care, ongoing primary care physician shortages, and favorable demographics. Growth is not uniform across the country — the Southeast, Southwest, and mid-Atlantic regions are currently the most active markets for new openings and M&A activity.

1.2 Market Structure

Source: UCA Center Counts Report (2024), Urgent Care Association; Medline Industry Analysis (2024).

1.3 Private Equity's Expanding Role

Private equity investment in urgent care has accelerated meaningfully since 2020. PE-backed operators now control approximately 17% of all US urgent care centers by count — but a disproportionately larger share of revenue and patient volume. Platforms like Concentra, CityMD/Summit Health, and American Family Care have grown aggressively through acquisition.

For independent operators, this creates both an opportunity and a competitive challenge. PE-backed buyers are well-capitalized and can move quickly on acquisitions. However, they are also highly selective — targeting clinics with strong EBITDA, defensible market positions, and clean financials.

Section 2: Core Valuation Methodologies

There is no single formula for valuing an urgent care clinic. In practice, buyers and their advisors use a combination of approaches, cross-referencing the results to arrive at a defensible range. The three primary methodologies used in 2025–2026 transactions are EBITDA-based, revenue-based, and comparable sales analysis.

2.1 EBITDA Multiple Method (Primary Method)

The EBITDA multiple approach is the dominant valuation methodology for urgent care transactions of any meaningful size. EBITDA — Earnings Before Interest, Taxes, Depreciation, and Amortization — serves as a proxy for a clinic's normalized operating cash flow.

The Core Formula: Clinic Value = Adjusted EBITDA × Market Multiple

Example: A clinic generating $800,000 in adjusted EBITDA at a 7x multiple = $5,600,000 enterprise value.

The word "Adjusted" is critical. Buyers will normalize EBITDA by adding back owner compensation above market rate, one-time expenses, non-recurring revenue, and personal charges run through the business.

2.2 EBITDA Multiples by Clinic Type (2025–2026)

Note: Multiples at the higher end reflect strong payer mix, diversified revenue (including occupational health), long-term lease stability, physician-owned or managed models with low provider turnover, and markets with limited competition.

2.3 Revenue Multiple Method

Revenue multiples are most commonly used for smaller clinics where EBITDA is thin or inconsistent, or as a secondary check on the EBITDA-based valuation. Industry benchmarks for 2025–2026 transactions suggest a range of 0.4x to 1.2x annual gross revenue, with the lower end reflecting commodity-level practices and the upper end reserved for high-margin, high-growth clinics.

Revenue multiples are generally less reliable for urgent care than EBITDA multiples, as gross revenue does not account for the widely varying cost structures across clinic types, staffing models, and payer mixes.

2.4 Comparable Sales (Comps) Analysis

Comparable sales analysis involves benchmarking a clinic against recent, similar transactions in the same geography. This approach requires access to deal data, which is rarely fully public in the healthcare space. Brokers, M&A advisors, and platforms like UrgentCareExchange are increasingly making this data accessible to independent operators.

Key comparables to examine include: closing price, EBITDA at close, number of locations, visit volume, payer mix, and market geography. A 3-location group in suburban Nashville commands a very different multiple than a 3-location group in rural Montana.

Section 3: Key Value Drivers in 2026

Understanding what moves the multiple is as important as understanding the multiple itself. In current deal activity, the following factors are the primary drivers of whether a clinic commands a premium or a discount.

3.1 Factors That Increase Value

• Diversified revenue beyond walk-in visits — particularly occupational medicine, employer contracts, and employer drug screening programs. Clinics with 20%+ of revenue from occ health consistently command higher multiples.
• Strong payer mix — a favorable balance of commercial insurance vs. Medicaid/self-pay significantly impacts EBITDA margin and buyer confidence. Buyers target 50%+ commercial payer mix as a baseline.
• Multi-location scale — the jump from single-site to 3+ locations is the single biggest multiple expansion event. It signals operational scalability and reduces key-person risk.
• Long-term lease stability — clinics with 5+ years remaining on favorable leases in high-traffic locations trade at a premium. Lease uncertainty is one of the most common reasons deals fall apart.
• Physician ownership or medical director stability — provider continuity reduces clinical risk. Buyer due diligence now includes significant scrutiny of provider contracts and non-competes.
• Technology infrastructure — modern EMR systems (especially those generating proprietary clinical data), integrated scheduling, and telehealth capabilities are increasingly valued.
• Clean financials — three years of clear, audited or reviewed financial statements materially reduce deal friction and support higher multiples. Many independently operated clinics lose 0.5x to 1.5x in multiple simply due to disorganized books.

3.2 Factors That Decrease Value

• High provider concentration risk — if one physician generates 40%+ of visits or revenue, buyers will price in significant risk of revenue loss post-close.
• Short or uncertain lease terms — particularly in competitive retail corridors where re-leasing at favorable rates is uncertain.
• Heavy Medicaid or uninsured payer mix — while underserved markets have social value, heavy government payer exposure reduces margins and limits buyer appetite.
• Deferred capital expenditures — aging equipment, outdated imaging, or facility disrepair becomes a negotiating point and reduces valuation.
• Pending litigation or compliance issues — unresolved billing audits, OSHA citations, or employment claims create liability uncertainty that buyers discount heavily.
• High provider cost structure — clinics paying above-market compensation to providers without corresponding volume justification will see EBITDA adjustments at due diligence.

UCX Insight: The Occupational Health Premium

In 2025 and into 2026, the most consistent value-add we see in UC transactions is occupational health integration. Clinics that have established employer accounts and drug screening programs often show EBITDA margins 5 to 8 percentage points higher than pure walk-in operations. This translates directly to higher multiples and faster deal timelines. If you are preparing for a sale in the next 12 to 24 months, building occ health revenue is likely the highest-return investment you can make.

Section 4: Deal Structures in 2026

4.1 Asset Sale vs. Stock Sale

The structure of an urgent care transaction — asset sale vs. stock sale — has significant tax and liability implications for both buyer and seller. Most urgent care transactions are structured as asset sales, particularly for smaller clinics, because buyers prefer not to inherit unknown liabilities.

4.2 Earnouts & Seller Financing

Earnouts — where a portion of the purchase price is contingent on post-close performance — are increasingly common in urgent care transactions. They allow buyers to manage risk while giving sellers upside if the business performs as represented. In 2025 deals, earnouts ranged from 10% to 30% of total deal value, typically tied to revenue or EBITDA targets over a 12 to 24-month period.

Seller financing (where the seller extends a loan to the buyer to cover part of the purchase price) is common in smaller transactions, particularly owner-operator sales under $2 million. Rates typically range from 6% to 9% with 3 to 7 year terms. SBA 7(a) loans are frequently used by buyers of single-site and small group practices and can cover up to $5 million of acquisition financing.

4.3 Equity Roll-Overs

In PE-backed transactions, sellers are increasingly offered the opportunity to retain a minority equity stake (typically 10% to 30%) in the acquiring platform. This 'roll equity' structure allows sellers to participate in future value creation as the platform scales. For strong operators considering a PE partnership, this structure can be highly lucrative if the platform successfully exits in a subsequent transaction.

Section 5: Preparing a Clinic for Sale

5.1 The 12-Month Preparation Checklist

• Organize three full years of P&L statements, tax returns, and balance sheets. Have them reviewed or audited if possible.
• Build an EBITDA normalization schedule — document every add-back with supporting evidence.
• Review and extend your lease if expiration is within 24 months of your target sale date.
• Assess and document all provider contracts, non-compete agreements, and medical director arrangements.
• Compile payer contract details: current reimbursement rates, contract terms, and renewal dates.
• Document operational systems: scheduling, EMR, billing workflows, and staffing protocols. Buyers pay more for systems-dependent businesses vs. people-dependent ones.
• Resolve any outstanding compliance issues: billing audits, OSHA, state licensing, CLIA waiver renewals.
• Benchmark your visit volume, revenue per visit, and EBITDA margin against industry averages.
• Identify and begin building your occupational health revenue line if not already established.
• Engage a healthcare M&A advisor or broker at least 6 months before your target market date.

5.2 Establishing a Defensible Asking Price

The single most common mistake sellers make is setting an asking price without reference to market data. Pricing a clinic too high creates market stigma — the longer a listing sits, the more buyers assume something is wrong. Pricing too low leaves significant value on the table.

A defensible asking price is built from the ground up: start with adjusted EBITDA, apply a supportable multiple range based on the clinic's specific characteristics, and then validate against recent comparable transactions. UCX and our network of advisors can assist operators in developing this analysis.

What Buyers Actually Look At First

When a buyer receives a deal package (CIM — Confidential Information Memorandum), the first three things they examine are: (1) Adjusted EBITDA and the quality of the add-backs, (2) payer mix breakdown, and (3) lease terms and location characteristics. Having clean, well-organized answers to these three questions is the single highest-leverage thing a seller can do to accelerate their deal and protect their multiple.

Section 6: What Buyers Are Paying — 2025 Transaction Data

Based on transaction activity tracked through UCX and industry sources, the following data reflects deal flow observed through Q4 2025. All figures are indicative ranges based on reported and disclosed transactions.

6.1 Deal Activity by Region

6.2 Notable Market Observations for 2026

• Interest rate stabilization has improved deal financing conditions compared to 2023–2024, which saw transaction volume slow as debt costs rose.
• Hospital system buyers have re-entered the market more aggressively in 2025, particularly targeting urgent care groups in their existing geographic footprints.
• Occupational health-integrated clinics are trading at a visible premium — typically 1.5x to 2x higher multiples than comparable pure walk-in operations.
• Single-site sales under $1M enterprise value continue to trade on a mix of asset and revenue multiples, with seller financing still common.
• Quality of earnings (QoE) reports — historically used only in large transactions — are increasingly requested by buyers in deals above $3M.

Conclusion

Valuing an urgent care clinic is part science and part market intelligence. The multiples matter, but the story behind the numbers matters just as much. Buyers in 2026 are sophisticated, well-advised, and highly selective. Sellers who enter the process prepared, with organized financials, a compelling narrative, and a realistic price expectation, consistently achieve better outcomes.

UrgentCareExchange was built to be the resource hub for every participant in this industry — from the single-site operator considering their first sale to the private equity group evaluating their next platform acquisition. Our AI-indexed marketplace, community forums, and vendor directory exist to give every player in urgent care the information and connections they need to make better decisions.

Connect with the UCX Community

• Have a question about your clinic's valuation? Post it in the UCX Community Forum — over 1,200 urgent care professionals are active on the platform.
• Thinking about listing your clinic for sale? Browse current buyer demand and comparable listings at urgentcareexchange.com.
• Looking for M&A advisors, brokers, or healthcare attorneys? Our AI-indexed Vendor Directory is the most comprehensive directory of UC-specific service providers available.

References & Sources

1. Urgent Care Association (UCA). Center Counts Report — September 2024.
2. Medline Healthcare. Expert Q&A: Benefits of Urgent Care Centers and Challenges — February 2025.
3. Marketplace.org / Kristin Schwab. Urgent Care Industry Grows as Need, Business Opportunity Meet — December 2022.
4. Urgent Care Association (UCA). About UCA: History and Mission — 2025.
5. Experity Health. 8 Principles for Improved Urgent Care Operation — 2024.
6. American Academy of Urgent Care Medicine (AAUCM). Frequently Asked Questions — Staffing, Operations, and Compliance.
7. DealStream. Medical Practices for Sale — Florida and National Market Data.
8. BizQuest. Urgent Care Practices For Sale — National Listings and Market Data.
9. American Family Care (AFC) Franchising. How Much Do Urgent Care Owners Make? — 2025.

© 2026 UrgentCareExchange.com

Frequently Asked Questions

Q: What is the primary method used to value an urgent care clinic in 2026?

The EBITDA multiple method is the dominant valuation methodology for urgent care transactions of any meaningful size. This approach calculates a clinic's value by multiplying its adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) by a market multiple, reflecting its normalized operating cash flow.

Q: Why is "Adjusted EBITDA" so important for urgent care clinic valuations?

"Adjusted" is critical because buyers will normalize EBITDA by adding back non-recurring expenses, owner compensation above market rates, one-time costs, and personal charges run through the business. This gives an accurate picture of the clinic's true operational profitability for a new owner.

Q: Do multi-location urgent care groups receive a higher valuation multiple than single-site clinics?

Yes, multi-location groups (typically 3+ sites) command a significant premium over single-site practices. The article indicates that scaling from a single-site to a multi-location model is considered the single biggest multiple expansion event, signaling operational scalability and reduced key-person risk to potential buyers.

Q: Besides visit volume, what are the key factors driving urgent care clinic valuations in 2026?

Beyond sheer volume, key value drivers include diversified revenue (especially occupational medicine or employer contracts), a strong commercial payer mix, stable and long-term lease agreements, and robust technology infrastructure. Things like staffing stability and geographic market position are also increasingly important.